InspireMD Inc. (NSPR) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

7/25

Growth 2 Margin 0 Expansion 3 Platform 0 Financial 2

latest quarter score

Earnings Reports

7
InspireMD (NSPR) Q1 2026: U.S. Commercial Pause Halts Guidance Despite 122% Revenue Surge
May 05, 2026
17
InspireMD (NSPR) Q4 2025: U.S. Revenue Jumps 74% Sequentially as C-Guard Prime Gains Traction
March 18, 2026
12
InspireMD (NSPR) Q3 2025: U.S. Launch Drives 39% Revenue Growth, Margin Leverage Building
November 04, 2025
12
InspireMD (NSPR) Q2 2025: $58M Capital Infusion Powers U.S. Launch Momentum
August 05, 2025
11
InspireMD (NSPR) Q2 2025: $58M Capital Infusion Fuels U.S. C-Guard Prime Launch Ramp
August 05, 2025

Browse all companies